Skip to the page

Data / Form D filings / Kamau Therapeutics, Inc.

Kamau Therapeutics, Inc.: Form D filing

Kamau Therapeutics, Inc., a technology company in South San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on June 3, 2025, reports $5 million sold of a $10 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
220 E. GRAND AVENUE, South San Francisco, CA, 94080
Phone
(628) 333-5084
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2071165

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 3, 2025New notice$10,000,000$4,999,997$5,000,0036May 19, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Raymond KelleherDirector
Matthew PorteusExecutive Officer, Director
Valentin BarsanExecutive Officer, Director
Ness BerminghamDirector

Other technology companies in California that filed recently

Every Form D from the week of Jun 2, 2025 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Kamau Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.